Intuitive Surgical financials
$412.18−0.63%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.89B | $2.77B | $2.87B | $2.51B | $2.44B | $2.25B | $2.41B | $2.04B | $2.01B | $1.89B | $1.93B | $1.74B |
| Gross profit | $1.96B | $1.83B | $1.90B | $1.66B | $1.62B | $1.46B | $1.64B | $1.37B | $1.37B | $1.25B | $1.28B | $1.17B |
| Gross margin | 67.8% | 66.1% | 66.4% | 66.4% | 66.3% | 64.7% | 68.0% | 67.4% | 68.3% | 65.9% | 66.2% | 66.9% |
| Operating income | $971.9M | $855.3M | $864.3M | $759.7M | $743.4M | $578.1M | $734.9M | $577.3M | $567.3M | $469.4M | $450.2M | $465.8M |
| Net income | $818.1M | $821.5M | $794.8M | $704.4M | $658.4M | $698.4M | $685.7M | $565.1M | $526.9M | $544.9M | $606.2M | $415.7M |
| Net margin | 28.3% | 29.6% | 27.7% | 28.1% | 27.0% | 31.0% | 28.4% | 27.7% | 26.2% | 28.8% | 31.4% | 23.8% |
| Diluted EPS | $2.29 | $2.28 | $2.21 | $1.95 | $1.81 | $1.92 | $1.88 | $1.56 | $1.46 | $1.51 | $1.69 | $1.16 |
| EBITDA | $1.01B | $876.4M | $1.50B | $772.6M | $755.7M | $590.2M | $1.19B | $590.2M | $477.2M | $587.2M | $450.2M | $582.1M |
| Operating cash flow | $1.06B | $911.9M | $892.5M | $841.0M | $715.4M | $581.6M | $822.6M | $706.5M | $620.5M | $265.4M | $228.3M | $548.4M |
| Free cash flow | $948.4M | $808.6M | $730.0M | $735.6M | $560.1M | $465.0M | $510.6M | $458.6M | $311.1M | $23.5M | -$207.2M | $292.1M |
| Diluted shares | 357.3M | 359.8M | 360.3M | 361.8M | 364.1M | 364.6M | 363.8M | 362.7M | 361.0M | 360.5M | 358.1M | 358.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.76B | $2.01B | $3.37B | $2.81B | $3.40B | $2.57B |
| Short-term investments | $2.46B | $2.51B | $2.57B | $2.10B | $1.92B | $1.94B |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $20.88B | $20.11B | $20.46B | $19.35B | $20.16B | $19.22B |
| Total liabilities | $2.58B | $2.51B | $2.52B | $2.31B | $2.21B | $2.01B |
| Shareholders' equity | $18.30B | $17.60B | $17.94B | $17.04B | $17.95B | $17.21B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology